A Review on polymers used in controlled drug delivery system
DOI:
https://doi.org/10.30904/j.wjpbt.2023.4605Keywords:
Polymers, controlled molecular, biological therapeutics, Pharmaceutical agents, conventional drug deliveryAbstract
Polymers have played an integral role in the advancement of drug delivery technology by providing controlled release of therapeutic agents in constant doses over long periods, cyclic dosage, and tunable release of both hydrophilic and hydrophobic drugs. From early beginnings using off-the-shelf materials, the field has grown tremendously, driven in part by the innovations of chemical engineers. Modern advances in drug delivery are now predicated upon the rational design of polymers tailored for specific cargo and engineered to exert distinct biological functions. In this review, we highlight the fundamental drug delivery systems and their mathematical foundations and discuss the physiological barriers to drug delivery. Hierarchical progress in modern drug delivery begins with the use of polymer carriers to elicit spatiotemporal release of therapeutics in both pulsatile dose delivery products and implanted reservoir systems. Although conventional drug delivery formulations have contributed greatly to the treatment of disease, the emergence of potent and specific biological therapeutics has escalated the impetus for intelligent delivery systems. Tremendous progress has been made as a result of the exploration of diffusion-controlled and solvent-activated formulations in drug delivery. Hydrogels and other polymer-based carriers have been developed to provide safe passage for pharmaceuticals through inhospitable physiological regions. Polymers of controlled molecular architecture can be engineered to give a well-defined response to external conditions as a result of a solid understanding of the underlying mechanisms and the nature of behavioral transitions. Polymers incorporated with therapeutics can be bioactive to provide their own therapeutic benefit or can be biodegradable to improve release kinetics and prevent carrier accumulation. Pharmaceutical agents have been conjugated to polymers to modify transport or circulation half-life characteristics as well as to allow for passive and active targeting.
Downloads
Published
Issue
Section
License
Copyright (c) 2023 Author

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.